PMI's Korean Facility Produces Non-Burning Heating Devices

Mar.27.2023

PMI's Korean factory, Liangshan, invests 300 billion KRW to produce Heets and Teria for IQOS in Korea and overseas.

On March 27th, 2FIRSTS learned that PhiMo International's South Korean manufacturing plant, Liangshan factory (Yangsan factory), has invested over 300 billion South Korean Won (approximately 1.6 billion yuan) since 2017 to produce non-combustible heating equipment, ensuring the demand in South Korea is met.

It is understood that since 2018, the Liangshan factory has been manufacturing specialized heating devices for electronic cigarettes that do not burn, called "Heets," and will begin production of IQOS Illuma series devices specifically designed for "Teria" in 2022.

Source: NEWSIS; Image of IQOS production line at a factory in Liangshan

The Liangshan factory not only produces and supplies all Heets and Teria products used for IQOS sales in Korea, but also exports them to seven countries where Illuma is sold.

There are a total of 10 Teria products, including 2 regular products, 4 new products, and 4 special products.

References:

2) Power Company's iQOS revolution continues to progress, pushing forward a smoke-free future as a game changer in the tobacco industry.

Philip Morris' Yangsan factory aims to export 'Teria' cigarettes exclusively to Iluma worldwide.

#Europe #United Kingdom #Market #PMI #Vaping devices #E-cigarette devices

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Australia TGA Warns Delivery Platforms: Don’t Promote or Supply Vapes Illegally

The Therapeutic Goods Administration (TGA) warned online delivery platforms not to breach Australian vape laws and said it worked with two major companies to remove non-compliant material. Under the Therapeutic Goods Act 1989, advertising vapes to the public is banned and sales are pharmacy-only; tobacconists and convenience stores cannot supply vapes. TGA will continue enforcement, with severe penalties for breaches.

Oct.30 by 2FIRSTS.ai

Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%

Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.

Nov.18 by 2FIRSTS.ai

Product | Up to 100,000 Puffs and Over 2,000 Puffs per ml: MASKKING, MR FOG, HYPERBAR Roll Out Ultra High-Puff New Devices

In 2025, disposable vapes are shifting from a “puff count race” to a focus on user experience. While 30,000–50,000 puffs has become mainstream, brands like MASKKING, MR FOG, and HYPERBAR are still launching higher-capacity products in the 60,000–100,000 puff range. Models with disclosed tank sizes all exceed 2,000 puffs per mL and commonly feature adjustable wattage and enhanced interactive functions.

Nov.14 by 2FIRSTS.ai

Canada’s B.C. Passes First Vaping Cost-Recovery Framework, Allowing Government to Sue Manufacturers Over Health Expenses

According to the Nelson Star, British Columbia has passed the Vaping Product Damages and Health Care Costs Recovery Act by a 49–42 vote. The legislation enables the provincial government to seek recovery of future public health costs from vape manufacturers, following models used in opioid and tobacco litigation.

Dec.03